Exploiting dendritic cells for active immunotherapy of cancer and chronic infections
- PMID: 17914192
- DOI: 10.1007/s12033-007-0020-6
Exploiting dendritic cells for active immunotherapy of cancer and chronic infections
Abstract
Dendritic cells (DCs) are important antigen-presenting cells (APCs) that can prime naive T cells and control adaptive immune responses with respect to magnitude, memory and self-tolerance. Understanding the biology of these cells is central to the development of new generation immunotherapies for cancer and chronic infections. This review presents a brief overview of DC biology and of the preparation and use of DC-based vaccines.
Similar articles
-
Exploiting dendritic cells for active immunotherapy of cancer and chronic infection.Methods Mol Med. 2005;109:1-18. Methods Mol Med. 2005. PMID: 15585909 Review.
-
Manipulating dendritic cell biology for the active immunotherapy of cancer.Blood. 2004 Oct 15;104(8):2235-46. doi: 10.1182/blood-2003-12-4392. Epub 2004 Jul 1. Blood. 2004. PMID: 15231572 Review.
-
Optimizing dendritic cell-based immunotherapy for cancer.Expert Rev Vaccines. 2007 Jun;6(3):333-45. doi: 10.1586/14760584.6.3.333. Expert Rev Vaccines. 2007. PMID: 17542749
-
Priming anticancer active specific immunotherapy with dendritic cells.Curr Opin Investig Drugs. 2005 Jun;6(6):576-81. Curr Opin Investig Drugs. 2005. PMID: 15988908 Review.
-
mRNA-based dendritic cell vaccines.Expert Rev Vaccines. 2015 Feb;14(2):161-76. doi: 10.1586/14760584.2014.957684. Epub 2014 Sep 8. Expert Rev Vaccines. 2015. PMID: 25196947 Review.
Cited by
-
A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy.Vaccine. 2009 Oct 9;27(43):6088-94. doi: 10.1016/j.vaccine.2009.05.016. Epub 2009 May 29. Vaccine. 2009. PMID: 19450647 Free PMC article. Clinical Trial.
-
In vivo imaging of immune cell trafficking in cancer.Eur J Nucl Med Mol Imaging. 2011 May;38(5):949-68. doi: 10.1007/s00259-010-1687-7. Epub 2010 Dec 18. Eur J Nucl Med Mol Imaging. 2011. PMID: 21170525 Review.
-
Chemotherapeutic agents in noncytotoxic concentrations increase antigen presentation by dendritic cells via an IL-12-dependent mechanism.J Immunol. 2009 Jul 1;183(1):137-44. doi: 10.4049/jimmunol.0900734. Epub 2009 Jun 17. J Immunol. 2009. PMID: 19535620 Free PMC article.
-
Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients.PLoS One. 2014 Apr 3;9(4):e93886. doi: 10.1371/journal.pone.0093886. eCollection 2014. PLoS One. 2014. PMID: 24699863 Free PMC article. Clinical Trial.
-
High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors.Vaccine. 2012 Jun 6;30(26):3908-17. doi: 10.1016/j.vaccine.2012.03.079. Epub 2012 Apr 10. Vaccine. 2012. PMID: 22497875 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous